‘Vaccine diplomacy’ sees Egypt roll out Chinese coronavirus jab

A lack of trial data transparency from China has raised concerns, but the country is confidently pushing ahead

When Egypt’s health ministry sent out an invitation to doctors to be vaccinated against Covid-19, they neglected to make clear it was a clinical trial.

Instead, it assured them that two Covid-19 vaccines developed by China’s National Biotec Group, part of a state-owned conglomerate known as Sinopharm, had no side-effects and that “the minister of health was vaccinated today, and orders were issued to vaccinate all doctors and workers who wish to be vaccinated”.

Continue reading...

Covid is a chance to build a world where everyone has access to basic vaccines | David Miliband and Anuradha Gupta

Preventable diseases still plague those missing out on vaccines. Efforts to halt coronavirus could help crack this issue

The massive public, private and foundation investments in a coronavirus vaccine are producing results at a record pace. And countries are reacting accordingly. A recent global assessment of purchasing agreements for Covid-19 vaccines reveals that high-income countries, as well as a few middle-income countries with high manufacturing capacity, have already bought enough doses for their populations.

But delivery of the vaccine needs a new level of focus. This is especially the case for populations in poor and war-torn countries, where the health system is weak or nonexistent. Even before the pandemic, approximately 20 million infants a year, often some of the most vulnerable in the world, were missing out on basic vaccines. For example, there are estimated to be more than 10.6 million children in the world’s poorest countries who in 2019 did not receive even a first dose of a diphtheria-pertussis-tetanus vaccine (DPT).

Continue reading...

Africa steps up fight against HIV with trial of new combination vaccines

African-led study expected to involve 1,600 people over next three years in Uganda, Tanzania, Mozambique and South Africa

The first trial in Africa to test two new vaccines to protect against HIV got under way in Uganda this week, raising hopes of an end to the epidemic that affects millions of people across the continent.

The African-led PrEPVacc study will test two experimental combination vaccines to see if they can provide any protection against HIV in people most at risk of infection.

Continue reading...

India’s biggest challenge: how to vaccinate 1.3bn people against Covid-19?

Analysis: Even with the world’s largest vaccination scheme already in place, the distribution at this scale has huge potential pitfalls

India’s claim to fame is staggering scale of its general elections, with 900 million voters mobilised across 1 million polling stations, to choose from 8,000 candidates across a landmass spanning 2,000 miles north to south and pretty much the same east to west.

But now the country has to go one better. India must vaccinate 1.3bn people against Covid-19 – twice and twice as fast. With more than 9 million confirmed cases of coronavirus and a battered economy, how will the country meet this challenge?

Continue reading...

World Bank ‘missed vital opportunities’ to support Covid response, says Oxfam

Millions forced to do without or pay for services as funding fails to adequately shore up healthcare systems, report finds

Millions of people in low-income countries have been forced to go without healthcare or have had to pay for it during the coronavirus pandemic, despite billions of pounds in emergency World Bank funding, research has found.

The World Bank’s $6bn (£4.45bn) emergency health fund to 71 countries in response to Covid-19 failed to strengthen health systems or remove financial barriers to using them, according to an Oxfam report published on Friday.

Continue reading...

RoboDoc: how India’s robots are taking on Covid patient care

The pandemic has spurred on robotics companies building machines to perform tasks in hospitals and other industries

Standing just 5ft tall, Mitra navigates around the hospital wards, guided by facial recognition technology and with a chest-mounted tablet that allows patients and their loved ones to see each other.

Developed in recent years by the Bengaluru startup Invento Robotics, Mitra costs around $13,600 (£10,000) and – due to the reduced risk of infection to doctors – has become hugely popular in Indian hospitals during the pandemic.

Continue reading...

Surge of Aids-related deaths feared as Covid pandemic puts gains at risk

UN calls for urgent focus on HIV/Aids as coronavirus blocks access to drugs and missed targets threaten to derail progress

Global progress on ending the Aids epidemic by 2030 could be blown off course by coronavirus, a senior UN director has warned.

Just a six-month disruption to medical supplies induced by Covid-19 could result in an extra 500,000 Aids-related deaths in sub-Saharan Africa by the end of 2021, according to data modelling in the annual report from UNAids. The agency’s executive director, Winnie Byanyima, said the world is already way off target on combating Aids, and the pandemic “has the potential to blow us even further off course”.

Continue reading...

Africa’s largest Covid treatment clinical trial launched by 13-country network

Anticov study with international research institutions aims to stop disease progression and protect fragile health systems

A network of 13 African countries has joined forces with global researchers to launch the largest clinical trial of potential Covid-19 treatments on the continent.

The Anticov study, involving Antwerp’s Institute of Tropical Medicine and international research institutions, aims to identify treatments that can be used to treat mild and moderate cases of Covid-19 early and prevent spikes in hospitalisation that could overwhelm fragile and already overburdened health systems in Africa.

Continue reading...

Scientists race to find ‘warm’ Covid vaccine to solve issue of cold storage

With potential injectable vaccines estimated to be out of reach for two-thirds of world’s population, scientists hope to find less-heat-sensitive formulations

News that one of the potential coronavirus vaccines had at least a 90% efficacy rate was a “victory for science”, said K Srinath Reddy, a cardiologist and president of the Public Health Foundation of India. But it meant little to his country’s 1.3 billion citizens.

“For us, the Pfizer vaccine is more of a scientific curiosity than a practical possibility,” Reddy said.

Continue reading...

Measles cases hit 20-year high as Covid disrupts vaccinations, report finds

Number of people dying from the disease also increased by 50% since 2016, according to data from the WHO and CDC

The number of measles cases worldwide surged to nearly 900,000 in 2019, the highest figure in more than two decades, underlining a significant U-turn in global progress to combat the disease.

Data from the World Health Organization (WHO) and US Centers for Disease Control and Prevention (CDC) found that the number of people dying from measles also increased by 50% since 2016, with an estimated 207,500 deaths in 2019 alone.

Continue reading...

Spike in yellow fever deaths prompts Nigeria to revive vaccination campaigns

Resurgence of disease linked to factors including climate crisis and focus of health resources on Covid response

More than 70 people are feared to have died of yellow fever in Nigeria since September, as health authorities warn of a resurgence of the disease.

The country recorded 47 deaths from yellow fever throughout the whole of 2019.

Continue reading...

Satellite imagery of Aden indicates scale of pandemic in Yemen

Academics’ analysis of burial plots points to excess deaths level in crisis-ridden country

A groundbreaking study using high-resolution satellite imagery to analyse graveyards has found that deaths have nearly doubled in Aden, the centre of Yemen’s coronavirus outbreak.

The discovery has given a sense of the true scale of the havoc the pandemic has wreaked on the vulnerable country.

Continue reading...

Tuberculosis breakthrough as scientists develop risk prediction tool

Data from tens of thousands of people around the world used to identify those at highest risk of active TB before they get sick

Scientists have developed a new tool to predict the chances of a person developing tuberculosis, which could help limit the spread of the disease and improve the life chances of millions of people .

Researchers at University College London (UCL) said they believe they have produced an algorithm that could help eliminate the disease in some countries.

Continue reading...

‘Not just a dog bite’: why India is struggling to keep rabies at bay

The government is being urged to dispel myths and ensure drugs are available – and take responsibility for the millions of stray dogs

By the time the patient, a young man, reached Dr Ramesh Masthi at a Bengaluru hospital, it was too late to save him. After being bitten by a pack of stray dogs as he went out to buy some milk, his family had applied a paste of green chillis, then lime juice and finally, when the wound looked gruesome, turmeric.

“He came about a week after he was bitten. The wound was serious, and we couldn’t save him. There is so much ignorance about dog bites and myths. A rabies shot in time would have saved him,” Masthi says.

Continue reading...

Hundreds of thousands with mental health conditions being chained, says charity

Adults and children are regularly shackled and locked up in 60 countries, report finds

Hundreds of thousands of people with mental health conditions in 60 countries are still being chained, according to a comprehensive and damning new study.

Human Rights Watch says that men, women and children – some as young as 10 – are regularly shackled or locked in confined spaces for weeks, months, and even years, across Asia, Africa, Europe, the Middle East, and the Americas.

Continue reading...

Malaria campaigns fight off Covid disruptions to deliver programmes

Almost all planned work against the disease has gone ahead this year, delivering nets, drugs and the world’s first malaria vaccine

More than 90% of anti-malaria campaigns planned this year across four continents are on track, despite disruptions caused by the coronavirus pandemic, according to new research.

The delivery of insecticide-treated nets and provision of antimalarial medicines in the majority of malaria-affected countries across Africa, Asia and the Americas were still going ahead, a high-level meeting organised by the RBM Partnership to End Malaria heard on Thursday.

Continue reading...

‘Confounding’: Covid may have already peaked in many African countries

One explanation for virus not behaving as expected could be previous exposure to other infections, experts tell MPs

The coronavirus pandemic has peaked earlier than expected in many African countries, confounding early predictions, experts have told MPs.

Scientists do not yet know why, but one hypothesis is the possibility of people having pre-existing immunity to Covid-19, caused by exposure to other infections.

Continue reading...

Africa’s triumph over wild polio shows the power of regional unity | Matshidiso Moeti

The legacy of a successful battle is now helping combat Covid, but we must stay vigilant, says WHO’s Africa regional director

Africa has declared victory over a virus that once paralysed 75,000 children on the continent every year.

Four years have now passed since wild polio was last detected in Africa. After a year of rigorously evaluating polio data from all 47 countries in the WHO’s African region, an independent body of experts announced during a virtual ceremony on Tuesdaythat the continent was free of wild polio.

Continue reading...

Africa to be declared free of wild polio after decades of work

Achievement comes following Nigeria vaccination drive, with last cases of wild virus recorded four years ago

Africa is expected to be declared free from wild polio, after decades of work by a coalition of international health bodies, national and local governments, community volunteers and survivors.

Four years after the last recorded cases of wild polio in northern Nigeria, the Africa Regional Certification Commission (ARCC) is expected to certify that the continent is free of the virus, which can cause irreversible paralysis and in some cases death.

Continue reading...

Lagos’s poor lament Covid fallout: ‘we don’t see the virus, we see suffering’

Lockdown has tipped many working-class Nigerians from struggle to crisis

Drawing open the curtains in Alapere, Lagos, unveils a sea of shanty roofs and watery-coloured housing blocks. “We don’t see any virus but we see suffering,” says Juliana Chokpa, a 38-year-old cleaner.

This working-class Lagos community has been reeling from job losses, a collapse in informal services, and rising food and transport costs. The pandemic, Chokpa says, has wrought a swift descent from struggle into crisis.

Continue reading...